RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
View Complete Description-
Hyperphosphatemia of chronic kidney disease.
Authors: Keith A Hruska, Suresh Mathew, Richard Lund, Ping Qiu, Raymond Pratt
Kidney international 2008 Jul -
Sevelamer hydrochloride: a review of its use for hyperphosphataemia in patients with end-stage renal disease on haemodialysis.
Authors: David R Goldsmith, Lesley J Scott, Risto S Cvetković, Greg L Plosker
Drugs 2008
Thought leaders and organizations working on research involving hyperphosphataemia.
- Mitsubishi Tanabe Pharma Corporation
- Shire Pharmaceutical Development
- Ineos Healthcare Limited
- Washington University School of Medicine
- Bayer
- Manchester Institute of Nephrology and Transplantation
- Washington University
- University Hospital Leuven
- Institute of Human Genetics
- Hospital Universitario de Canarias
-
Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia
conditions: Chronic Kidney Failure
interventions: Fermagate ; Sevelamer HCl
-
The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients
conditions: Hyperphosphatemia
interventions: Niacinamide
-
Oral sodium phosphate laxative inducing hyperphosphatemia relates with weight?
Science Centric. - January 21, 2010 -
Hyperphosphatemia following standard OSP doses is related to weight, reveals study
News-Medical. - January 18, 2010
Community
-
No NextBio users were found for “hyperphosphataemia”.
Complete your user profile with your interests, if you want others to find you within the NextBio community.
-
No NextBio groups were found for “hyperphosphataemia”.
Be the first to start a group and share your interests with others within the NextBio community.
